Investing Profile

Robert Nelsen

VCInvestorAngel

Co-founder and a Managing Director of ARCH Venture Partners

archventure.com/team/robert-t...New York, New York

Your Intro Paths to Robert Nelsen

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Robert Nelsen on

Current Investing Position

ARCH Venture Partners Managing Director

Investment Range

$50K - $150.0M

Sweet Spot

$75.0M

Investments On Record

Current Fund Size

$635.8M

Robert Nelsen is on these Sector & Stage Rankings

Therapeutics (Seed)Wellness & Fitness (Seed)Digital Health (Seed)BioTech (Seed)AI (Seed)SaaS (Seed)Therapeutics (Series A)Wellness & Fitness (Series A)Digital Health (Series A)BioTech (Series A)AI (Series A)SaaS (Series A)Seattle / Portland Midwest Angel, Scout, and Solo-Capitalists New York City San Francisco Bay Area

Robert Nelsen's Investments On Record (51)

Company	StageDateRound Size	Total Raised
Stability AI	Series UnknownJun 2024$80M	$210M £89M
Co-investors: Colin Bryant (New Enterprise Associates (NEA)), Gaurav Gupta (Lightspeed Venture Partners), Effie Epstein (Sound Ventures), Guy Oseary (Sound Ventures), Ashton Kutcher (Sound Ventures), Chris Denny-Brown (O'Shaughnessy Ventures), Walter Kortschak (Summit Partners), Jim O'Shaughnessy (O'Shaughnessy Ventures), Eric Schmidt (Innovation Endeavors), Dana Settle (Greycroft), Mei Z.
Vilya	Series AJun 2024$21M Series AAug 2022$50M	$71M
Co-investors: Greg Yap (Menlo Ventures), Steven Gillis (ARCH Venture Partners)
Gameto	Series BMay 2024$33M Series AJan 2022$20M	$73M
Co-investors: Dylan Morris (Insight Partners), Dan Rose (Coatue), Maryanna Saenko (Future Ventures), Steve Jurvetson (Future Ventures), Laura Stoppel (RA Capital), Jack Abraham (Atomic), Dusan Perovic (Two Sigma Ventures), Peter Kolchinsky (RA Capital), Anne Wojcicki
Xaira Therapeutics	Series AApr 2024$1B	$1B
Co-investors: Scott Gottlieb (New Enterprise Associates (NEA)), Vikram Bajaj (Foresite Capital)
Seaport Therapeutics	Series AApr 2024$100M	$100M
Co-investors: James Healy (Sofinnova Investments)
Moonwalk Biosciences	Series AJan 2024$57M	$57M
Recuro Health	Series BApr 2023$47M Convertible NoteMar 2022 Series AAug 2021$15M	$62M
Co-investors: Mitchel Laskey (DeepWork Capital), Mike Moradi
Aera Therapeutics	Series AFeb 2023 Series BFeb 2023$190M	$190M
Co-investors: Issi Rozen (GV (Google Ventures)), David Schenkein (GV (Google Ventures)), Josh Wolfe (Lux Capital)